GSC
RNXT icon

Ground Swell Capital’s RenovoRx RNXT Stock Holding History

Ground Swell Capital’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,611
Closed -$11.4K – 167
2025
Q4 		$11.4K Buy
+13,611
New +$13.6K 0.02% 71
2023
Q4 		– Sell
-11,481
Closed -$14.5K – 107
2023
Q3 		$14.5K Buy
+11,481
New +$20.7K 0.02% 66

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Ground Swell Capital's RNXT Position: Q1 2026 in Review

Ground Swell Capital sold out of RenovoRx (RNXT) in Q1 2026, closing a stake of 13,611 shares — an estimated $11.4K sold.

Ground Swell Capital first reported a position in RNXT in Q3 2023 and held it in 2 quarters. The position peaked at $14.5K in Q3 2023. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.

  • Ground Swell Capital reported no remaining RenovoRx position as of Q1 2026 after selling out during the quarter.
  • Ground Swell Capital sold 13,611 RenovoRx shares in Q1 2026, an estimated $11.4K.
  • Ground Swell Capital first reported a position in RenovoRx in Q3 2023 and held it in 2 quarters.
  • Ground Swell Capital's RenovoRx position peaked at $14.5K in Q3 2023.
  • 31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.

Based on Ground Swell Capital's 13F filing for Q1 2026, filed 21 Apr 2026.